BOULDER, Colo. (AP) — BOULDER, Colo. (AP) — Fresh Tracks Therapeutics, Inc. (FRTX) on Monday reported profit of $1.9 million in its third quarter.
On a per-share basis, the Boulder, Colorado-based company said it had net income of 32 cents.
The drug developer posted revenue of $7.9 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FRTX at https://www.zacks.com/ap/FRTX